Search

Your search keyword '"Boels, Katrin"' showing total 7 results
Start Over Author "Boels, Katrin"
7 results on '"Boels, Katrin"'

2. Bradykinin B2 and GPR100 receptors: a paradigm for receptor signal transduction pharmacology

Author

Meini, Stefania, Bellucci, Francesca, Cucchi, Paola, Giuliani, Sandro, Quartara, Laura, Giolitti, Alessandro, Zappitelli, Sabrina, Rotondaro, Luigi, Boels, Katrin, and Maggi, Carlo Alberto

Subjects
Special Reports, Dose-Response Relationship, Drug, Receptor, Bradykinin B2, Cricetinae, Receptors, Bradykinin, Animals, Humans, CHO Cells, Bradykinin, Signal Transduction
Abstract

The aim of the present report was to investigate the ligand selectivity of the human orphan G-protein-coupled receptor GPR100 (hGPR100), recently identified as a novel bradykinin (BK) receptor, as compared with that of the human B(2) receptor (hB(2)R) stably transfected in Chinese hamster ovary cells. BK was able to inhibit the cAMP production induced by forskolin with a potency 100-fold lower at the hGPR100 (pEC(50) = 6.6) than that measured at the hB(2)R (pEC(50) = 8.6). Both effects were inhibited by the B(2) receptor antagonist Icatibant (1 microM). The nonpeptide B(2) receptor agonist FR190997 (8-[2,6-dichloro-3-[N-methylcarbamoyl)cinnamidoacetyl]-N-methylamino]benzyloxy]-2-methyl-4-(2-pyridylmethoxy)quinoline) did inhibit the forskolin-induced cAMP production (pEC(50) = 7.7) at the hB(2)R, whereas it was not able to exert any effect at the hGPR100. The human insulin-like peptide relaxin 3 did inhibit the cAMP production at the hGPR100 (pEC(50) = 7.3) at a greater extent than BK, and was devoid of any effect at the hB(2)R. FR190997 and relaxin 3 responses at the hB(2)R and hGPR100, respectively, were not inhibited by Icatibant (1 microM). These data indicate FR190997 and relaxin 3 as selective agonists for hB(2)R and hGPR100, respectively, and support the concept that different agonists may specifically bias the conformational states of a receptor to result in a final common G protein coupling, which is differentially recognized by antagonists.

Published
2004

7. Bradykinin B2 and GPR100 receptors: a paradigm for receptor signal transduction pharmacology.

Author

Meini, Stefania, Bellucci, Francesca, Cucchi, Paola, Giuliani, Sandro, Quartara, Laura, Giolitti, Alessandro, Zappitelli, Sabrina, Rotondaro, Luigi, Boels, Katrin, and Alberto Maggi, Carlo

Subjects
LIGANDS (Biochemistry), G proteins, BRADYKININ, FORSKOLIN, PEPTIDES, OVARIES, CELLS
Abstract

The aim of the present report was to investigate the ligand selectivity of the human orphan G-protein- coupled receptor GPR 100 (hGPR 100), recently identified as a novel bradykinin (BK) receptor, as compared with that of the human B2 receptor (hB2R) stably transfected in Chinese hamster ovary cells. BK was able to inhibit the cAMP production induced by forskolin with a potency 100-fold lower at the hGPR100 (pEC50 = 6.6) than that measured at the hB2R (pEC50 = 8.6). Both effects were inhibited by the B2 receptor antagonist Icatibant (1 pM). The nonpeptide B2 receptor agonist FR 190997 (8 -[2, 6-dichloro-3 -[N-methylcarbamoyl)cinnamidoacetyl]-N-methylamino]benzyloxy]-2- methyl-4-( 2 -pyridylmethoxy)quinoline) did inhibit the forskolin-induced cAMP production (pEC50 = 7.7) at the hB2R, whereas it was not able to exert any effect at the hGPR100. The human insulin-like peptide relaxin 3 did inhibit the cAMP production at the hGPR 100 (pEC50 = 7.3) at a greater extent than BK, and was devoid of any effect at the hB2R. FR 190997 and relaxin 3 responses at the hB2R and hGPR100, respectively, were not inhibited by Icatibant (1 μM). These data indicate FR190997 and relaxin 3 as selective agonists for hB2R and hGPR100, respectively, and support the concept that different agonists may specifically bias the conformational states of a receptor to result in a final common 0 protein coupling, which is differentially recognized by antagonists. [ABSTRACT FROM AUTHOR]

Published
2004
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results